Case for staged thyroidectomy.
completion thyroidectomy
morbidity
partial thyroidectomy
total thyroidectomy
Journal
Head & neck
ISSN: 1097-0347
Titre abrégé: Head Neck
Pays: United States
ID NLM: 8902541
Informations de publication
Date de publication:
10 2020
10 2020
Historique:
received:
28
04
2020
revised:
01
06
2020
accepted:
09
07
2020
pubmed:
8
8
2020
medline:
22
6
2021
entrez:
8
8
2020
Statut:
ppublish
Résumé
Recent modifications in the management of well-differentiated thyroid cancer have resulted in significant alterations in clinical approach. Utilizing a series of preoperative and postoperative risk factors involving both the patient and the disease pathology, we offer the term "staged thyroidectomy" to help organize these risk factors for patients and the endocrine team to optimize management. This approach is intended to incorporate our latest nuanced understanding of certain endocrine pathology and may serve to optimize patient outcomes.
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
3061-3071Informations de copyright
© 2020 Wiley Periodicals LLC.
Références
Haugen BR, Alexander EK, Bible KC, et al. 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association Guidelines Task Force on thyroid nodules and differentiated thyroid cancer. Thyroid. 2016;26(1):1-133. https://doi.org/10.1089/thy.2015.0020.
National Comprehensive Cancer Network, Inc. Thyroid Cancer 2019. www.nccn.org/professionals/physician_gls/PDF/thyroid.pdf. Accessed November 30, 2019.
Hauch A, Al-Qurayshi Z, Randolph G, Kandil E. Total thyroidectomy is associated with increased risk of complications for low- and high-volume surgeons. Ann Surg Oncol. 2014;21(12):3844-3852. https://doi.org/10.1245/s10434-014-3846-8.
Pasieka JL, Thompson NW, McLeod MK, Burney RE, Macha M. The incidence of bilateral well-differentiated thyroid cancer found at completion thyroidectomy. World J Surg. 1992;16(4):711-717. https://doi.org/10.1007/bf02067365.
Kim ES, Kim TY, Koh JM, et al. Completion thyroidectomy in patients with thyroid cancer who initially underwent unilateral operation. Clin Endocrinol (Oxf). 2004;61(1):145-148. https://doi.org/10.1111/j.1365-2265.2004.02065.x.
Lamartina L, Grani G, Durante C, Borget I, Filetti S, Schlumberger M. Follow-up of differentiated thyroid cancer-what should (and what should not) be done. Nat Rev Endocrinol. 2018;14(9):538-551. https://doi.org/10.1038/s41574-018-0068-3.
Gulcelik MA, Dogan L, Akgul GG, Guven EH, Ersoz Gulcelik N. Completion thyroidectomy: safer than thought. Oncol Res Treat. 2018;41(6):386-390. https://doi.org/10.1159/000487083.
Li Y-J, Wang Y-Z, Yi Z-B, Chen L-L, Zhou X-D. Comparison of completion thyroidectomy and primary total surgery for differentiated thyroid cancer: a meta-analysis. Oncol Res Treat. 2015;38(10):528-531. https://doi.org/10.1159/000440690.
Sena G, Gallo G, Innaro N, et al. Total thyroidectomy vs completion thyroidectomy for thyroid nodules with indeterminate cytology/follicular proliferation: a single-centre experience. BMC Surg. 2019;19(1):87. https://doi.org/10.1186/s12893-019-0552-2.
Park YM, Kim J-R, Oh KH, et al. Comparison of functional outcomes after total thyroidectomy and completion thyroidectomy: hypoparathyroidism and postoperative complications. Auris Nasus Larynx. 2019;46(1):101-105. https://doi.org/10.1016/j.anl.2018.03.009.
Hirshoren N, Kaganov K, Weinberger JM, et al. Thyroidectomy practice after implementation of the 2015 American Thyroid Association Guidelines on surgical options for patients with well-differentiated thyroid carcinoma. JAMA Otolaryngol Head Neck Surg. 2018;144(5):427-432. https://doi.org/10.1001/jamaoto.2018.0042.
Untch BR, Palmer FL, Ganly I, et al. Oncologic outcomes after completion thyroidectomy for patients with well-differentiated thyroid carcinoma. Ann Surg Oncol. 2014;21(4):1374-1378. https://doi.org/10.1245/s10434-013-3428-1.
Mishra A, Mishra SK. Total thyroidectomy for differentiated thyroid cancer: primary compared with completion thyroidectomy. Eur J Surg. 2002;168(5):283-287. https://doi.org/10.1002/ejs.47.
Shaha AR, Jaffe BM. Completion thyroidectomy: a critical appraisal. Surgery. 1992;112(6):1143-1148.
Shaha AR, Michael Tuttle R. Completion thyroidectomy-indications and complications. Eur J Surg Oncol. 2019;45(7):1129-1131. https://doi.org/10.1016/j.ejso.2019.03.028.
Nikiforov YE. Radiation-induced thyroid cancer: what we have learned from Chernobyl. Endocr Pathol. 2006;17(4):307-317. https://doi.org/10.1007/s12022-006-0001-5.
Charkes ND. On the prevalence of familial nonmedullary thyroid cancer in multiply affected kindreds. Thyroid. 2006;16(2):181-186. https://doi.org/10.1089/thy.2006.16.181.
Capezzone M, Marchisotta S, Cantara S, et al. Familial non-medullary thyroid carcinoma displays the features of clinical anticipation suggestive of a distinct biological entity. Endocr Relat Cancer. 2008;15(4):1075-1081. https://doi.org/10.1677/ERC-08-0080.
Nixon IJ, Suarez C, Simo R, et al. The impact of family history on non-medullary thyroid cancer. Eur J Surg Oncol. 2016;42(10):1455-1463. https://doi.org/10.1016/j.ejso.2016.08.006.
Son EJ, Nosé V. Familial follicular cell-derived thyroid carcinoma. Front Endocrinol (Lausanne). 2012;3(MAY):1-6. https://doi.org/10.3389/fendo.2012.00061.
Barney BM, Hitchcock YJ, Sharma P, Shrieve DC, Tward JD. Overall and cause-specific survival for patients undergoing lobectomy, near-total, or total thyroidectomy for differentiated thyroid cancer. Head Neck. 2011;33(5):645-649. https://doi.org/10.1002/hed.21504.
Ito Y, Miyauchi A, Oda H. Low-risk papillary microcarcinoma of the thyroid: a review of active surveillance trials. Eur J Surg Oncol. 2018;44(3):307-315. https://doi.org/10.1016/j.ejso.2017.03.004.
Ito Y, Miyauchi A, Higashiyama T, Masuoka H, Kihara M, Miya A. Older age significantly affects mortality of patients with papillary thyroid carcinoma only when they have high-risk features. World J Surg. 2020;44(6):1885-1891. https://doi.org/10.1007/s00268-020-05429-x.
Mendelsohn AH, Elashoff DA, Abemayor E, St John MA. Surgery for papillary thyroid carcinoma. Arch Otolaryngol Neck Surg. 2010;136(11):1055-1061. https://doi.org/10.1001/archoto.2010.181.
Kuba S, Yamanouchi K, Hayashida N, et al. Total thyroidectomy versus thyroid lobectomy for papillary thyroid cancer: comparative analysis after propensity score matching: a multicenter study. Int J Surg. 2017;38:143-148. https://doi.org/10.1016/j.ijsu.2016.09.083.
Adam MA, Pura J, Gu L, et al. Extent of surgery for papillary thyroid cancer is not associated with survival: an analysis of 61,775 patients. Ann Surg. 2014;260(4):601-607. https://doi.org/10.1097/SLA.0000000000000925.
Or K, Benbassat C, Koren S, et al. Adherence to ATA 2015 guidelines in the management of unifocal non-invasive papillary thyroid cancer: a clinical survey among endocrinologists and surgeons. Eur Arch Otorhinolaryngol. 2018;275(11):2851-2859. https://doi.org/10.1007/s00405-018-5126-x.
Haymart MR, Banerjee M, Yang D, et al. The relationship between extent of thyroid cancer surgery and use of radioactive iodine. Ann Surg. 2013;258(2):354-358. https://doi.org/10.1097/SLA.0b013e31826c8915.
Baum JE, Soong L, Scognamiglio T, Margolskee EM, Hoda RS, Rao R. Cytological diagnosis of papillary thyroid carcinoma with tall cells on ThinPrep liquid-based cytology. Diagn Cytopathol. 2019;47(6):541-546. https://doi.org/10.1002/dc.24146.
Tanaka A, Hirokawa M, Higuchi M, et al. Diagnostic clues indicating tall cell variants of papillary thyroid carcinoma in fine needle aspiration. Diagn Cytopathol. 2019;47(5):452-457. https://doi.org/10.1002/dc.24122.
Nath MC, Erickson LA. Aggressive variants of papillary thyroid carcinoma: hobnail, tall cell, columnar, and solid. Adv Anat Pathol. 2018;25(3):172-179. https://doi.org/10.1097/PAP.0000000000000184.
Michels JJ, Jacques M, Henry-Amar M, Bardet S. Prevalence and prognostic significance of tall cell variant of papillary thyroid carcinoma. Hum Pathol. 2007;38(2):212-219. https://doi.org/10.1016/j.humpath.2006.08.001.
Leung AK-C, Chow S-M, Law SCK. Clinical features and outcome of the tall cell variant of papillary thyroid carcinoma. Laryngoscope. 2008;118(1):32-38. https://doi.org/10.1097/MLG.0b013e318156f6c3.
Khadra H, Mohamed H, Al-Qurayshi Z, Sholl A, Killackey M, Kandil E. Superior detection of metastatic cystic lymphadenopathy in patients with papillary thyroid cancer by utilization of thyroglobulin washout. Head Neck. 2019;41(1):225-229. https://doi.org/10.1002/hed.25488.
Gonçalves Filho J, Zafereo ME, Ahmad FI, et al. Decision making for the central compartment in differentiated thyroid cancer. Eur J Surg Oncol. 2018;44(11):1671-1678. https://doi.org/10.1016/j.ejso.2018.08.005.
Lesnik D, Cunnane ME, Zurakowski D, et al. Papillary thyroid carcinoma nodal surgery directed by a preoperative radiographic map utilizing CT scan and ultrasound in all primary and reoperative patients. Head Neck. 2014;36(2):191-202. https://doi.org/10.1002/hed.23277.
Vuong HG, Altibi AMA, Duong UNP, Hassell L. Prognostic implication of BRAF and TERT promoter mutation combination in papillary thyroid carcinoma-a meta-analysis. Clin Endocrinol (Oxf). 2017;87(5):411-417. https://doi.org/10.1111/cen.13413.
Tessler FN, Middleton WD, Grant EG, et al. ACR thyroid imaging, reporting and data system (TI-RADS): white paper of the ACR TI-RADS Committee. J Am Coll Radiol. 2017;14(5):587-595. https://doi.org/10.1016/j.jacr.2017.01.046.
Ibrahim B, Forest V-I, Hier M, Mlynarek AM, Caglar D, Payne RJ. Completion thyroidectomy: predicting bilateral disease. J Otolaryngol Head Neck Surg. 2015;44:23. https://doi.org/10.1186/s40463-015-0076-4.
Kluijfhout WP, Pasternak JD, Lim J, et al. Frequency of high-risk characteristics requiring total thyroidectomy for 1-4 cm well-differentiated thyroid cancer. Thyroid. 2016;26(6):820-824. https://doi.org/10.1089/thy.2015.0495.
Williamson AG, Wilmot V, Ntala C, Gibb FW, Conn B, Nixon IJ. Differentiated thyroid cancer: a retrospective evaluation of the impact of changes to disease management guidelines on patients in South East Scotland. Surgeon. 2019;17(2):73-79. https://doi.org/10.1016/j.surge.2018.05.002.
Huang H, Liu S, Xu Z, Ni S, Zhang Z, Wang X. Long-term outcome of thyroid lobectomy for unilateral multifocal papillary carcinoma. Medicine (United States). 2017;96(27):1-4. https://doi.org/10.1097/MD.0000000000007461.
Iacobone M, Jansson S, Barczyński M, Goretzki P. Multifocal papillary thyroid carcinoma-a consensus report of the European Society of Endocrine Surgeons (ESES). Langenbecks Arch Surg. 2014;399(2):141-154. https://doi.org/10.1007/s00423-013-1145-7.
Amit M, Boonsripitayanon M, Goepfert RP, et al. Extrathyroidal extension: does strap muscle invasion alone influence recurrence and survival in patients with differentiated thyroid cancer? Ann Surg Oncol. 2018;25(11):3380-3388. https://doi.org/10.1245/s10434-018-6563-x.
Amit M, Boonsripitayanon M, Zafereo ME. ASO author reflections: strap muscle invasion does not influence recurrence and survival in patients with differentiated thyroid cancer. Ann Surg Oncol. 2018;25(s3):892-893. https://doi.org/10.1245/s10434-018-6816-8.
Seo YL, Yoon DY, Lim KJ, et al. Locally advanced thyroid cancer: can CT help in prediction of extrathyroidal invasion to adjacent structures? AJR Am J Roentgenol. 2010;195(3):W240-W244. https://doi.org/10.2214/AJR.09.3965.
Lee DY, Kwon T-K, Sung M-W, Kim KH, Hah JH. Prediction of extrathyroidal extension using ultrasonography and computed tomography. Int J Endocrinol 2014;2014:351058. doi:https://doi.org/10.1155/2014/351058, 1, 6
Kamaya A, Tahvildari AM, Patel BN, Willmann JK, Jeffrey RB, Desser TS. Sonographic detection of extracapsular extension in papillary thyroid Cancer. J Ultrasound Med. 2015;34(12):2225-2230. https://doi.org/10.7863/ultra.15.02006.
Tam S, Amit M, Boonsripitayanon M, et al. Effect of tumor size and minimal extrathyroidal extension in patients with differentiated thyroid cancer. Thyroid. 2018;28(8):982-990. https://doi.org/10.1089/thy.2017.0513.
Shaha AR. Extrathyroidal extension-what does it mean. Oral Oncol. 2017;68:50-52. https://doi.org/10.1016/j.oraloncology.2017.03.008.
Staubitz JI, Musholt PB, Musholt TJ. The surgical dilemma of primary surgery for follicular thyroid neoplasms. Best Pract Res Clin Endocrinol Metab. 2019;33(4):101292. https://doi.org/10.1016/j.beem.2019.101292.
Ito Y, Hirokawa M, Masuoka H, et al. Prognostic factors of minimally invasive follicular thyroid carcinoma: extensive vascular invasion significantly affects patient prognosis. Endocr J. 2013;60(5):637-642. https://doi.org/10.1507/endocrj.ej12-0419.
Cibas ES, Ali SZ. The 2017 Bethesda system for reporting thyroid cytopathology. Thyroid. 2017;27(11):1341-1346. https://doi.org/10.1089/thy.2017.0500.
Grisales J, Sanabria A. Utility of routine frozen section of thyroid nodules classified as follicular neoplasm: meta-analysis of diagnostic tests. Am J Clin Pathol. 2019;153(2):210-220. https://doi.org/10.1093/ajcp/aqz152.
Raffaelli M, De Crea C, D'Amato G, et al. Post-thyroidectomy hypocalcemia is related to parathyroid dysfunction even in patients with normal parathyroid hormone concentrations early after surgery. Surgery. 2016;159(1):78-84. https://doi.org/10.1016/j.surg.2015.07.038.
Payne RJ, Hier MP, Tamilia M, Mac Namara E, Young J, Black MJ. Same-day discharge after total thyroidectomy: the value of 6-hour serum parathyroid hormone and calcium levels. Head Neck. 2005;27(1):1-7. https://doi.org/10.1002/hed.20103.
Lombardi CP, Raffaelli M, Princi P, et al. Parathyroid hormone levels 4 hours after surgery do not accurately predict post-thyroidectomy hypocalcemia. Surgery. 2006;140(6):1015-1016. https://doi.org/10.1016/j.surg.2006.08.009.
Merchavy S, Marom T, Forest VI, et al. Comparison of the incidence of postoperative hypocalcemia following total thyroidectomy vs completion thyroidectomy. Otolaryngol Head Neck Surg. 2015;152(1):53-56. https://doi.org/10.1177/0194599814556250.
Schneider R, Randolph GW, Dionigi G, et al. International neural monitoring study group guideline 2018 part I: staging bilateral thyroid surgery with monitoring loss of signal. Laryngoscope. 2018;128 Suppl:S1-S17. https://doi.org/10.1002/lary.27359.
Randolph GW, Daniels GH. Radioactive iodine lobe ablation as an alternative to completion thyroidectomy for follicular carcinoma of the thyroid. Thyroid. 2002;12(11):989-996. https://doi.org/10.1089/105072502320908321.
Kisaoglu A, Ozogul B, Akcay MN, et al. Completion thyroidectomy in differentiated thyroid cancer: when to perform? Ulus Cerrahi Derg. 2014;30(1):18-21. https://doi.org/10.5152/UCD.2014.2486.
Tan MP, Agarwal G, Reeve TS, Barraclough BH, Delbridge LW. Impact of timing on completion thyroidectomy for thyroid cancer. Br J Surg. 2002;89(6):802-804. https://doi.org/10.1046/j.1365-2168.2002.02068.x.
Bin Saleem R, Bin Saleem M, Bin Saleem N. Impact of completion thyroidectomy timing on post-operative complications: a systematic review and meta-analysis. Gland Surg. 2018;7(5):458-465. https://doi.org/10.21037/gs.2018.09.03.
Vargas-Pinto S, Romero Arenas MA. Lobectomy compared to Total thyroidectomy for low-risk papillary thyroid cancer: a systematic review. J Surg Res. 2019;242:244-251. https://doi.org/10.1016/j.jss.2019.04.036.
Barbesino G, Goldfarb M, Parangi S, Yang J, Ross DS, Daniels GH. Thyroid lobe ablation with radioactive iodine as an alternative to completion thyroidectomy after hemithyroidectomy in patients with follicular thyroid carcinoma: long-term follow-up. Thyroid. 2012;22(4):369-376. https://doi.org/10.1089/thy.2011.0198.
Ullmann TM, Gray KD, Stefanova D, et al. The 2015 American Thyroid Association guidelines are associated with an increasing rate of hemithyroidectomy for thyroid cancer. Surgery. 2019;166(3):349-355. https://doi.org/10.1016/j.surg.2019.03.002.
Shrime MG, Goldstein DP, Seaberg RM, et al. Cost-effective management of low-risk papillary thyroid carcinoma. Arch Otolaryngol Head Neck Surg. 2007;133(12):1245-1253. https://doi.org/10.1001/archotol.133.12.1245.
Al-Qurayshi Z, Nooureldine SI, Tufano RP, Kandil E. Total thyroidectomy vs lobectomy in patient with suspicious for papillary thyroid cancer nodule on fine-needle-aspiration: cost-effectiveness analysis. J Am Coll Surg. 2016;223:s46. https://doi.org/10.1016/j.jamcollsurg.2016.06.115.
Lang BH-H, Wong CKH. Lobectomy is a more cost-effective option than total thyroidectomy for 1 to 4 cm papillary thyroid carcinoma that do not possess clinically recognizable high-risk features. Ann Surg Oncol. 2016;23(11):3641-3652. https://doi.org/10.1245/s10434-016-5280-6.
Stern S, Hilly O, Horowitz E, Leshno M, Feinmesser R. Is there justification for Total thyroidectomy in low-risk papillary thyroid carcinoma? A decision-analysis model. World J Surg. 2015;39(11):2707-2717. https://doi.org/10.1007/s00268-015-3167-5.
Grani G, Ramundo V, Verrienti A, Sponziello M, Durante C. Thyroid hormone therapy in differentiated thyroid cancer. Endocrine. 2019;66(1):43-50. https://doi.org/10.1007/s12020-019-02051-3.
O'Hara MW, Ghoneim MM, Hinrichs JV, Mehta MP, Wright EJ. Psychological consequences of surgery. Psychosom Med. 1989;51(3):356-370. https://doi.org/10.1097/00006842-198905000-00010.
Pitt SC, Wendt E, Saucke MC, et al. A qualitative analysis of the preoperative needs of patients with papillary thyroid cancer. J Surg Res. 2019;244:324-331. https://doi.org/10.1016/j.jss.2019.06.072.
Salari B, Hammon RJ, Kamani D, Randolph GW. Staged surgery for advanced thyroid cancers: safety and oncologic outcomes of neural monitored surgery. Otolaryngol Head Neck Surg. 2017;156(5):816-821. https://doi.org/10.1177/0194599817697189.
Patel N, Scott-Coombes D. Impact of surgical volume and surgical outcome assessing registers on the quality of thyroid surgery. Best Pract Res Clin Endocrinol Metab. 2019;33(4):101317. https://doi.org/10.1016/j.beem.2019.101317.
Aspinall S, Oweis D, Chadwick D. Effect of surgeons' annual operative volume on the risk of permanent hypoparathyroidism, recurrent laryngeal nerve palsy and haematoma following thyroidectomy: analysis of United Kingdom registry of endocrine and thyroid surgery (UKRETS). Langenbecks Arch Surg. 2019;404(4):421-430. https://doi.org/10.1007/s00423-019-01798-7.